Diclofenac Epolamine topical system 1.3%
$105.00/Visit
Prescriber visit fee for new prescriptions
Low systemic exposure, suitable for diverse patients and pain sites.
Pain relief achieved within 4 hours, sustained for 7 days with twice-daily application.
Patented patch technology delivers NSAID power for 12 hours.
$105.00/Visit
Prescriber visit fee for new prescriptions
A Different Way to Treat Pain
For many patients suffering from acute pain due to a strain or sprain, an oral medication may deliver relief systemically when only localized action is needed. That’s why Diclofenac Epolamine Topical System 1.3% is a prescription NSAID topical system designed to deliver powerful pain-reducing medicine directly to where it hurts. Its targeted delivery offers low potential for systemic exposure compared to oral options.
Understanding Acute Pain
Acute pain is short-term pain, often described as a stabbing, burning, or squeezing sensation. It results from minor injuries, including strains, sprains, and contusions (bruises). While acute pain may be brief, it is a signal of tissue damage. The goal of treatment is to reduce the pain, redness, swelling, and heat (inflammation) associated with these injuries.
Adding Support to Your Pain Regimen
Many individuals are seeking alternatives to traditional oral pain relievers. Adding a topical NSAID system to your pain management toolbox may provide extra support when you need it most. Diclofenac Epolamine Topical System 1.3% offers a 12-hour, mess-free patch application with localized absorption, giving you a proven choice for treating acute pain exactly where it hurts.
IMPORTANT SAFETY INFORMATION
Diclofenac epolamine topical system 1.3% contains diclofenac epolamine, which is a nonsteroidal anti-inflammatory drug (NSAID), and is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions
INDICATIONS AND USAGE
WARNING: RISK OF SERIOUS CARDIOVASCULAR
and GASTROINTESTINAL EVENTS
Cardiovascular Thrombotic Events
- Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an
increased risk of serious cardiovascular thrombotic events,
including myocardial infarction and stroke, which can be fatal. This risk may occur early in the treatment and may increase with duration of use. - Diclofenac epolamine topical system 1.3% is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.
Gastrointestinal Bleeding, Ulceration, and Perforation
- NSAIDs cause an increased risk of serious gastrointestinal
(GI) adverse events including bleeding, ulceration, and
perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at
greater risk for serious GI events.